Cullinan Therapeutics (CGEM) EBIT Margin (2021)
Cullinan Therapeutics (CGEM) has 1 years of EBIT Margin data on record, last reported at 7.24% in Q1 2021.
- For Q1 2021, EBIT Margin changed N/A year-over-year to 7.24%; the TTM value through Dec 2021 reached 358.73%, changed N/A, while the annual FY2021 figure was 358.73%, N/A changed from the prior year.
- EBIT Margin reached 7.24% in Q1 2021 per CGEM's latest filing.
- Across five years, EBIT Margin topped out at 7.24% in Q1 2021 and bottomed at 7.24% in Q1 2021.